menu
    • menu

    Company profile for Santa Ana Bio

    NEW Drugs in Dev: 1
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Santa Ana Bio, based in the Bay Area, specializes in harnessing its multiomics and protein engineering platforms to develop precision biologics tailored for treating severe immune-related diseases. By integrating advanced technologies in multiomics (such as genomics, proteomics, and metabolomics) and protein engineering, the company aims to design innovative therapies that target specific immune mechanisms underlying these dis...
    Santa Ana Bio, based in the Bay Area, specializes in harnessing its multiomics and protein engineering platforms to develop precision biologics tailored for treating severe immune-related diseases. By integrating advanced technologies in multiomics (such as genomics, proteomics, and metabolomics) and protein engineering, the company aims to design innovative therapies that target specific immune mechanisms underlying these diseases. Santa Ana Bio is committed to advancing personalized medicine and improving outcomes for patients facing challenging immune-related conditions through its cutting-edge biotechnological approaches.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Santa Ana BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1105 Atlantic Avenue, Suite 104 Alameda, California, 94501
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.santaanabio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/santaanabio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Santa Ana Bio Names Newman Yeilding As Chief Medical Officer
    Santa Ana Bio Names Newman Yeilding As Chief Medical Officer

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210773636/en/Santa-Ana-Bio-Announces-the-Appointment-of-Newman-Yeilding-as-Chief-Medical-Officer

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Santa Ana Bio Names Mike Bonney Chair Of Board
    Santa Ana Bio Names Mike Bonney Chair Of Board

    11 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111626849/en/Santa-Ana-Bio-Announces-the-Appointment-of-Mike-Bonney-as-Chair-of-the-Board

    BUSINESSWIRE
    11 Nov 2025
    Share Share
    TPG tops up funds to $580M for investments across the life sciences spectrum
    TPG tops up funds to $580M for investments across the life sciences spectrum

    06 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tpg-tops-funds-580m-investments-across-life-sciences-spectrum

    FIERCE BIOTECH
    06 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search